Immunomedics, Inc. (IMMU) Reports Q4 EPS of 3c
Tweet
Share
E-mailGet Alerts IMMU Hot Sheet
Price: $87.86 --0%
Financial Fact:
Unrealized gain on securities available for sale - net: -32.61K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Unrealized gain on securities available for sale - net: -32.61K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Immunomedics, Inc. (NASDAQ: IMMU) reported Q4 EPS of $0.03, $0.09 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $11.1 million versus the consensus estimate of $3.43 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
- ScanSource (SCSC) Tops Q4 EPS by 32c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
